Polypharmacy and medication regimen complexity in older patients with hemophilia or von willebrand disease: the M’HEMORRH-AGE study-Reference-Cited by-同舟云学术

Polypharmacy and medication regimen complexity in older patients with hemophilia or von willebrand disease: the M’HEMORRH-AGE study

Published:2022-06-15 Issue:4 Volume:44 Page:922-929
ISSN:2210-7703
Container-title:International Journal of Clinical Pharmacy
language:en
Short-container-title:Int J Clin Pharm

Author:

Novais Teddy,Prudent Christelle,Cransac Amélie,Gervais Frederic,Jouglen Julien,Gigan Mickael,Cahoreau Véronique,Chamouard Valérie

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy

Link

https://link.springer.com/content/pdf/10.1007/s11096-022-01401-y.pdf

Reference26 articles.

1. Centre de Référence Hémophilie et autres déficits constitutionnels en protéines de la coagulation. Protocole National de Diagnostic et de Soins (PNDS) Hémophilie. Version n°3. [Internet]. 2019. Available on: https://www.has-sante.fr/upload/docs/application/pdf/2019-10/pnds_hemophilie_argumentaire_10.10.19.pdf.

2. Darby SC, Kan SW, Spooner RJ, et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood. 2007;110(3):815–25.

3. Hassan S, Monahan RC, Mauser-Bunschoten EP, et al. Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001–2018. J Thromb Haemost JTH. 2021;19(3):645–53.

4. Franchini M, Mannucci PM. Co-morbidities and quality of life in elderly persons with haemophilia. Br J Haematol. 2010;148(4):522–33.

5. Hermans C, de Moerloose P, Dolan G. Clinical management of older persons with haemophilia. Crit Rev Oncol Hematol. 2014;89(2):197–206.